Report of Foreign Issuer (6-k)
October 30 2018 - 4:33PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2018
Commission File Number: 001-34541
GLOBAL CORD BLOOD CORPORATION
(Translation of registrants name into English)
48
th
Floor, Bank of China Tower
1 Garden Road
Central
Hong Kong S.A.R.
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
o
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
If Yes is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- .
This report and each of the exhibits to this report are hereby incorporated by reference into the registration statements on Form F-3 (No. 333-183143 and No. 333-213730) of the Company.
Other Events
Attached hereto as Exhibit 99.1 is a Notice of Annual General Meeting of Shareholders, Proxy Statement and Form of Proxy of Global Cord Blood Corporation (the Company) relating to the Companys 2018 Annual General Meeting.
Where to Find Additional Information
The Company is a foreign private issuer. As such, the Proxy Statement is not subject to review and comment by the Securities and Exchange Commission (the SEC).
Shareholders are urged to carefully read the Proxy Statement, because it contains important information about the Company and the 2018 Annual General Meeting of Shareholders. Copies of the Proxy Statement and other documents filed or submitted by the Company will be available at the website maintained by the SEC at www.sec.gov. Shareholders may obtain a copy of such filings and the Companys annual report, free of charge, from the Companys website at www.globalcordbloodcorp.com, by contacting our Investor Relations Department at: ir@globalcordbloodcorp.com or by writing to us at 48
th
Floor, Bank of China Tower, 1 Garden Road, Central, Hong Kong S.A.R., ATTN: Secretary.
Participants in the Solicitation
The Company and its directors and executive officers may be deemed to be participants in the solicitation of proxies from the shareholders of the Company in connection with the 2018 Annual General Meeting of Shareholders. Information regarding certain directors and executive officers of the Company is available in the Companys documents filed with or submitted to the SEC. Other information regarding the participants in the proxy solicitation and descriptions of their direct and indirect interests, by security holdings or otherwise, are set forth in the Proxy Statement filed herewith.
Exhibits
Exhibit No.
|
|
Description
|
99.1
|
|
Notice of Annual General Meeting of Shareholders, Proxy Statement and Form of Proxy
|
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
GLOBAL CORD BLOOD CORPORATION
|
|
By:
|
/s/ Albert Chen
|
|
Name:
|
Albert Chen
|
|
Title:
|
Chief Financial Officer
|
Dated: October 30, 2018
3
Global Cord Blood (NYSE:CO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Global Cord Blood (NYSE:CO)
Historical Stock Chart
From Sep 2023 to Sep 2024